Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (5): 2292-2230.doi: 10.11843/j.issn.0366-6964.2025.05.027

• Preventive Veterinary Medicine • Previous Articles     Next Articles

Evaluation of the Characteristics of Eudragit L100-Modified Aluminum-Manganese Metal-Organic Framework as an Oral Delivery Vehicle for Inactivated Porcine Epidemic Diarrhea Vaccine

HU Mi1(), SHEN Yaoxin1,2, FAN Baochao1, SUN Min1, ZHOU Jinzhu1, GUO Rongli1, LI Bin1,*()   

  1. 1. Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
    2. School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212000, China
  • Received:2024-07-02 Online:2025-05-23 Published:2025-05-27
  • Contact: LI Bin E-mail:bomdiami@163.com;libinana@126.com

Abstract:

This study aims to evaluate aluminum-manganese bimetallic organic framework nanoparticles modified with Eudragit L100 as an oral delivery vehicle for inactivated porcine epidemic diarrhea virus (PEDV). By utilizing the coordination interaction between metal ions (Al3+, Mn2+) and the organic ligand 2-aminoterephthalic acid, inactivated PEDV is encapsulated in situ within Al/Mn-MOF to form Al/Mn-MOF@PEDV nanoparticles. An anionic polymer, Eudragit L100, is then electrostatically attached to the surface of Al/Mn-MOF@PEDV nanoparticles, producing L100@Al/Mn-MOF@PEDV nanoparticles. The morphology is examined using scanning electron microscopy, the surface charge is measured by zeta potential meter, the composition is analyzed by fourier transform infrared spectroscopy, and the crystal structure is determined by X-ray Diffraction. The loading efficiency of inactivated PEDV is characterized using ELISA and antigen detection cards. The stability of L100@Al/Mn-MOF@PEDV nanoparticles in simulated gastric fluid and the release rate of inactivated PEDV are examined using ELISA. Macrophage uptake of the nanoparticles is observed using confocal laser scanning microscopy. The cytotoxicity of nanoparticles with different concentrations is determined by CCK8 method, and the effect on the secretion of immunomodulatory factors by macrophages is evaluated using ELISA kits. Results indicate successful preparation of L100@Al/Mn-MOF@PEDV nanoparticles, with sizes under 1 μm. At a PEDV/metal ion/organic ligand ratio of 0.42 ∶1 ∶1, the loading rate of inactivated PEDV reaches 99.6%. After 2 hours in simulated gastric fluid, L100@Al/Mn-MOF@PEDV nanoparticles maintained high stability with only about 12.73% release rate of inactivated PEDV. Uptake experiments in mouse RAW264.7 cells show enhanced uptake of Al/Mn-MOF@PEDV compared to unencapsulated inactivated PEDV. Additionally, Al/Mn-MOF@PEDV significantly boosts the expression of Th1-type factor IFN-γ and Th2-type factor IL-4 in RAW264.7 cells. This research offers new insights into the design of oral carriers for inactivated PED vaccines and lays the foundation for future applications in animal immunization.

Key words: PEDV, inactivated vaccine, nanoparticle carrier, metal-organic framework, oral delivery

CLC Number: